欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2151/002
药品名称Budesonide/Formoterol Genetic
活性成分
    • budesonide 160.0 µg/dose
    • Formoterolfumarat dihydrate 4.5 µg/dose
剂型Inhalation powder, hard capsule
上市许可持有人Genetic S.p.A., Italy
参考成员国 - 产品名称Sweden (SE)
Budesonide/Formoterol Genetic
互认成员国 - 产品名称
    • Poland (PL)
      Budesonide + Formoterol Genetic
    • Greece (GR)
许可日期2022/06/27
最近更新日期2022/07/26
药物ATC编码
    • R03AK07 formoterol and budesonide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Withdrawn（注：已撤市）
    撤市原因：1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase